CLINICAL_TRIALS
trial_result
· 2020-02-12
Clinical Trial Update: Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma [Phase 2]
Summary
Phase 2 trial of pazopanib in surgically unresectable or metastatic chondrosarcoma completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emerald Clinical Inc. | Conditions: Chondrosarcoma, Metastatic Chondrosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2020-02-12